Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$16.07 - $31.84 $119,416 - $236,603
7,431 Added 1.52%
497,088 $14.4 Million
Q1 2024

May 02, 2024

BUY
$17.13 - $26.91 $168,062 - $264,014
9,811 Added 2.04%
489,657 $10.1 Million
Q4 2023

Feb 01, 2024

SELL
$21.58 - $29.5 $30.5 Million - $41.6 Million
-1,411,038 Reduced 74.62%
479,846 $13 Million
Q3 2023

Oct 31, 2023

BUY
$25.8 - $39.97 $10.4 Million - $16.1 Million
403,475 Added 27.13%
1,890,884 $56 Million
Q2 2023

Aug 03, 2023

BUY
$20.94 - $38.01 $31.1 Million - $56.5 Million
1,487,409 New
1,487,409 $53.2 Million
Q1 2022

May 11, 2022

SELL
$48.25 - $100.49 $8.07 Million - $16.8 Million
-167,226 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$88.71 - $120.43 $45.2 Million - $61.4 Million
-509,718 Reduced 75.3%
167,226 $16.7 Million
Q3 2021

Nov 09, 2021

SELL
$98.77 - $132.17 $807,444 - $1.08 Million
-8,175 Reduced 1.19%
676,944 $84.6 Million
Q2 2021

Aug 12, 2021

SELL
$109.77 - $165.68 $224 Million - $339 Million
-2,043,552 Reduced 74.89%
685,119 $85.1 Million
Q1 2021

May 11, 2021

SELL
$127.04 - $179.1 $35.4 Million - $49.8 Million
-278,306 Reduced 9.26%
2,728,671 $417 Million
Q4 2020

Feb 05, 2021

SELL
$99.96 - $135.93 $17 Million - $23.2 Million
-170,468 Reduced 5.36%
3,006,977 $388 Million
Q3 2020

Nov 04, 2020

SELL
$80.32 - $111.8 $12.7 Million - $17.6 Million
-157,764 Reduced 4.73%
3,177,445 $355 Million
Q2 2020

Aug 06, 2020

BUY
$60.49 - $97.5 $44.6 Million - $71.9 Million
737,024 Added 28.37%
3,335,209 $271 Million
Q1 2020

May 06, 2020

SELL
$59.04 - $88.81 $3.78 Million - $5.69 Million
-64,048 Reduced 2.41%
2,598,185 $181 Million
Q4 2019

Feb 07, 2020

SELL
$59.49 - $82.78 $42.4 Million - $59.1 Million
-713,456 Reduced 21.14%
2,662,233 $208 Million
Q3 2019

Nov 08, 2019

BUY
$62.59 - $110.3 $38.9 Million - $68.6 Million
622,154 Added 22.59%
3,375,689 $215 Million
Q2 2019

Aug 06, 2019

BUY
$63.94 - $91.11 $132 Million - $188 Million
2,068,098 Added 301.72%
2,753,535 $0
Q1 2019

May 10, 2019

SELL
$34.3 - $97.98 $5.42 Million - $15.5 Million
-157,883 Reduced 18.72%
685,437 $52.6 Million
Q4 2018

Feb 06, 2019

BUY
$29.2 - $46.1 $24.6 Million - $38.9 Million
843,320 New
843,320 $31.7 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.64B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.